Back to NGNE
JPMORGAN CHASE & CO NGNE Position History
Neurogene Inc. • Healthcare
Quarters held
24
Latest value
$50K
Q3 2026
Peak value
$1.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $868K |
| Q1 2025 | $137K |
| Q1 2025 | $14K |
| Q2 2025 | $70K |
| Q2 2025 | $11K |
| Q2 2025 | $14K |
| Q3 2025 | $5K |
| Q3 2025 | $69K |
| Q3 2025 | $22K |
| Q3 2025 | $5K |
| Q3 2025 | $69K |
| Q3 2025 | $22K |
| Q4 2025 | $5K |
| Q4 2025 | $81K |
| Q4 2025 | $24K |
| Q1 2026 | $1.1M |
| Q1 2026 | $168K |
| Q1 2026 | $24K |
| Q2 2026 | $1.7M |
| Q2 2026 | $275K |
| Q2 2026 | $43K |
| Q3 2026 | $1.4M |
| Q3 2026 | $273K |
| Q3 2026 | $50K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $50K | 1.7K | — | — |
| Q3 2026 | $273K | 9.6K | — | — |
| Q3 2026 | $1.4M | 50.6K | — | — |
| Q2 2026 | $43K | 1.3K | — | — |
| Q2 2026 | $275K | 8.5K | — | — |
| Q2 2026 | $1.7M | 52.1K | — | — |
| Q1 2026 | $24K | 1.2K | — | — |
| Q1 2026 | $168K | 8.7K | — | — |
| Q1 2026 | $1.1M | 55.0K | — | — |
| Q4 2025 | $24K | 1.2K | — | — |
| Q4 2025 | $81K | 3.9K | — | — |
| Q4 2025 | $5K | 266 | — | — |
| Q3 2025 | $22K | 1.3K | — | — |
| Q3 2025 | $69K | 4.0K | — | — |
| Q3 2025 | $5K | 310 | — | — |
| Q3 2025 | $22K | 1.3K | — | — |
| Q3 2025 | $69K | 4.0K | — | — |
| Q3 2025 | $5K | 310 | — | — |
| Q2 2025 | $14K | 955 | — | — |
| Q2 2025 | $11K | 728 | — | — |
| Q2 2025 | $70K | 4.7K | — | — |
| Q1 2025 | $14K | 1.2K | — | — |
| Q1 2025 | $137K | 11.7K | — | — |
| Q1 2025 | $868K | 74.1K | — | — |
Other funds holding NGNE
$51.9M
$51.7M
$48.6M
$44.4M
$44.1M
$43.5M
$42.8M